Qingbo Lv

876 total citations
48 papers, 604 citations indexed

About

Qingbo Lv is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Qingbo Lv has authored 48 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 14 papers in Molecular Biology. Recurrent topics in Qingbo Lv's work include Coronary Interventions and Diagnostics (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (3 papers). Qingbo Lv is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (3 papers). Qingbo Lv collaborates with scholars based in China and United States. Qingbo Lv's co-authors include Guosheng Fu, Aimin Wu, Yong-Long Chi, Wenbin Zhang, Meihui Wang, Boxuan Ma, Jun Lin, Haiming Jin, Yuliang Mao and Chao Ni and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Qingbo Lv

45 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingbo Lv China 14 168 155 117 91 82 48 604
Yun Zhou China 14 286 1.7× 148 1.0× 58 0.5× 21 0.2× 50 0.6× 66 669
Zhihong Xu China 14 172 1.0× 330 2.1× 48 0.4× 77 0.8× 28 0.3× 46 730
Qingyu Liu China 18 223 1.3× 189 1.2× 114 1.0× 26 0.3× 42 0.5× 88 943
Asako Yamamoto Japan 15 145 0.9× 215 1.4× 111 0.9× 24 0.3× 31 0.4× 67 771
Hui Jiang China 14 227 1.4× 177 1.1× 26 0.2× 34 0.4× 44 0.5× 50 636
Yayuan Zheng China 15 248 1.5× 62 0.4× 89 0.8× 31 0.3× 30 0.4× 27 745
Gen Kuroyanagi Japan 14 335 2.0× 155 1.0× 34 0.3× 28 0.3× 44 0.5× 90 695
Benling Qi China 12 146 0.9× 82 0.5× 23 0.2× 88 1.0× 34 0.4× 38 439
Quan Li China 16 141 0.8× 241 1.6× 116 1.0× 22 0.2× 49 0.6× 38 545

Countries citing papers authored by Qingbo Lv

Since Specialization
Citations

This map shows the geographic impact of Qingbo Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbo Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbo Lv more than expected).

Fields of papers citing papers by Qingbo Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbo Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbo Lv. The network helps show where Qingbo Lv may publish in the future.

Co-authorship network of co-authors of Qingbo Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbo Lv. A scholar is included among the top collaborators of Qingbo Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbo Lv. Qingbo Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Harry, Jian Gao, Lian See Tan, et al.. (2025). Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer. Advanced Functional Materials. 35(48).
2.
Lu, Zhao‐Yang, Qing Chai, Wenbin Dai, et al.. (2025). Mitochondrial homeostasis restoring peptide-drug conjugates with ROS-responsive NO releasing ability for targeted therapy of myocardial infarction. Journal of Nanobiotechnology. 23(1). 496–496. 3 indexed citations
3.
Zhou, Yuanyuan, Qingbo Lv, Rui Gu, et al.. (2024). Identification of potential diagnostic genes for atherosclerosis in women with polycystic ovary syndrome. Scientific Reports. 14(1). 18215–18215. 3 indexed citations
4.
Lv, Qingbo, Yao Wang, Meihui Wang, et al.. (2024). Proline metabolic reprogramming modulates cardiac remodeling induced by pressure overload in the heart. Science Advances. 10(19). eadl3549–eadl3549. 6 indexed citations
5.
Lv, Qingbo, et al.. (2023). Targeting Nanoplatform for Atherosclerosis Inhibition and Degradation via a Dual‐Track Reverse Cholesterol Transport Strategy. Small. 20(7). e2306457–e2306457. 5 indexed citations
6.
Zhang, Ning, Mengkang Fan, Yongchao Zhao, et al.. (2023). Biomimetic and NOS‐Responsive Nanomotor Deeply Delivery a Combination of MSC‐EV and Mitochondrial ROS Scavenger and Promote Heart Repair and Regeneration. Advanced Science. 10(21). e2301440–e2301440. 37 indexed citations
7.
Yu, Pengcheng, Xinyu Zhou, Yuxing Wang, et al.. (2023). Andrographolide protects against atrial fibrillation by alleviating oxidative stress injury and promoting impaired mitochondrial bioenergetics. Journal of Zhejiang University SCIENCE B. 24(7). 632–649. 9 indexed citations
8.
Lin, Jun, Qinfeng Li, Tingting Jin, et al.. (2022). Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis. Cell Death and Disease. 13(1). 90–90. 23 indexed citations
9.
Sun, Shuo, Xia Sheng, Xianglan Liu, et al.. (2022). Transcriptome analysis uncovers the autophagy‐mediated regulatory patterns of the immune microenvironment in dilated cardiomyopathy. Journal of Cellular and Molecular Medicine. 26(14). 4101–4112. 4 indexed citations
10.
Ma, Boxuan, Yun Xiao, Qingbo Lv, et al.. (2022). Targeting Theranostics of Atherosclerosis by Dual‐Responsive Nanoplatform via Photoacoustic Imaging and Three‐In‐One Integrated Lipid Management. Advanced Materials. 35(5). e2206129–e2206129. 48 indexed citations
11.
Li, Ya, et al.. (2022). Prognostic significance of troponin increment after percutaneous coronary intervention: A retrospective study. Frontiers in Cardiovascular Medicine. 9. 833522–833522.
12.
Lv, Qingbo, Boxuan Ma, Wujiao Li, et al.. (2022). Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction. Frontiers in Chemistry. 10. 943009–943009. 13 indexed citations
13.
Li, Qingfeng, Tingting Jin, Jun Lin, et al.. (2021). Downregulation of activating transcription factor 4 attenuates lysophosphatidycholine-induced inflammation via the NF-κB pathway. European Journal of Pharmacology. 911. 174457–174457. 5 indexed citations
14.
Li, Ya, Yi Luan, Qingbo Lv, et al.. (2020). Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study. Journal of Thoracic Disease. 12(10). 5398–5410. 5 indexed citations
15.
Shen, Zhida, Jiaqi Zhou, Xiaoou Chen, et al.. (2020). Weighted gene co-expression network analysis identified underlying hub genes and mechanisms in the occurrence and development of viral myocarditis. Annals of Translational Medicine. 8(21). 1348–1348. 8 indexed citations
16.
Wang, Min, Qingbo Lv, Yao Wang, et al.. (2019). Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway. Experimental and Therapeutic Medicine. 19(2). 871–882. 5 indexed citations
17.
Shao, Zhenxuan, Fang Xia, Qingbo Lv, et al.. (2018). Comparison of combined anterior–posterior approach versus posterior-only approach in neuromuscular scoliosis: a systematic review and meta-analysis. European Spine Journal. 27(9). 2213–2222. 9 indexed citations
18.
Lv, Qingbo, Xiang Gao, Dingsheng Lin, et al.. (2016). Effects of diammonium glycyrrhizinate on random skin flap survival in rats: An experimental study. Biomedical Reports. 5(3). 383–389. 9 indexed citations
19.
Lv, Qingbo, et al.. (2015). Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis. Clinical & Translational Oncology. 18(3). 322–330. 60 indexed citations
20.
Wu, Aimin, et al.. (2015). Minimum 4-Year Outcomes of Cervical Total Disc Arthroplasty Versus Fusion. Medicine. 94(15). e665–e665. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yun Zhou Breakdown of academic impact, for papers by Zhihong Xu Breakdown of academic impact, for papers by Qingyu Liu Breakdown of academic impact, for papers by Asako Yamamoto Breakdown of academic impact, for papers by Hui Jiang Breakdown of academic impact, for papers by Yayuan Zheng Breakdown of academic impact, for papers by Gen Kuroyanagi Breakdown of academic impact, for papers by Benling Qi Breakdown of academic impact, for papers by Quan Li
Rankless by CCL
2026